Evidence suggests that certain oncogenic pathways and cell cycle regulators such as NF-kB, PI3K/mTOR, hedgehog and polo-like kinase 1 (PLK1) are overexpressed and activated in high risk neuroblastoma [6–15]. The gene discussed is MTOR; the disease is neuroblastoma.